title: [Clinical effects of paxil in poststroke rehabilitation].
abstract: The efficacy of antidepressant paxil was studied in 30 patients, aged 30-70 years, who had survived stroke in the interior carotid arteries area, with pronounced affective disorders (illness duration over 3 months). Paxil was prescribed in an initial dosage of 20 mg daily during 12 weeks. A significant clinical antidepressive and anxiolytic effect of paxil was observed and confirmed by the data of cluster analysis. An inclusion of paxil in a complex of rehabilitative measures allowed to improve patients quality of life.
authors.forename: I E
authors.initials: IE
authors.lastname: Poverennova
authors.forename: I A
authors.initials: IA
authors.lastname: Zolotovskaia
mesh_terms: D000328:Adult; D000368:Aged; D001921:Brain / Q000098:blood supply* / Q000503:physiopathology; D002343:Carotid Artery, Internal / Q000503:physiopathology; D002544:Cerebral Infarction / Q000503:physiopathology / Q000523:psychology* / Q000534:rehabilitation*; D016000:Cluster Analysis; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000627:therapeutic use*; D011788:Quality of Life / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors